These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6711309)

  • 21. Neutralization of tetanus toxin by distinct monoclonal antibodies binding to multiple epitopes on the toxin molecule.
    Volk WA; Bizzini B; Snyder RM; Bernhard E; Wagner RR
    Infect Immun; 1984 Sep; 45(3):604-9. PubMed ID: 6205994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-expression of tetanus toxin fragment C in Escherichia coli with thioredoxin and its evaluation as an effective subunit vaccine candidate.
    Yu YZ; Gong ZW; Ma Y; Zhang SM; Zhu HQ; Wang WB; Du Y; Wang S; Yu WY; Sun ZW
    Vaccine; 2011 Aug; 29(35):5978-85. PubMed ID: 21718736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines-part 1.
    Winsnes R; Sesardic D; Daas A; Behr-Gross ME
    Pharmeuropa Bio; 2004 Jan; 2003(2):35-68. PubMed ID: 14960262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit.
    Isaka M; Yasuda Y; Kozuka S; Miura Y; Taniguchi T; Matano K; Goto N; Tochikubo K
    Vaccine; 1998 Oct; 16(17):1620-6. PubMed ID: 9713937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Determination of tetanus toxin and toxoid by ELISA using monoclonal antibodies].
    Burkin MA; Sviridov VV; Perelygina OV
    Prikl Biokhim Mikrobiol; 2004; 40(4):478-84. PubMed ID: 15455723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A single-dose cytomegalovirus-based vaccine encoding tetanus toxin fragment C induces sustained levels of protective tetanus toxin antibodies in mice.
    Tierney R; Nakai T; Parkins CJ; Caposio P; Fairweather NF; Sesardic D; Jarvis MA
    Vaccine; 2012 Apr; 30(20):3047-52. PubMed ID: 22414558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors affecting the immunogenicity of tetanus toxin fragment C expressed in Lactococcus lactis.
    Norton PM; Brown HW; Wells JM; Macpherson AM; Wilson PW; Le Page RW
    FEMS Immunol Med Microbiol; 1996 Jun; 14(2-3):167-77. PubMed ID: 8809553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies against the light chain of tetanus toxin in human sera.
    Lin CS; Habig WH; Hardegree MC
    Infect Immun; 1985 Jul; 49(1):111-5. PubMed ID: 2409006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection against tetanus toxin in mice nasally immunized with recombinant Lactococcus lactis expressing tetanus toxin fragment C.
    Norton PM; Wells JM; Brown HW; Macpherson AM; Le Page RW
    Vaccine; 1997; 15(6-7):616-9. PubMed ID: 9178460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A vaccination strategy incorporating DNA priming and mucosal boosting using tetanus toxin fragment C (TetC).
    Stratford R; Douce G; Bowe F; Dougan G
    Vaccine; 2001 Nov; 20(3-4):516-25. PubMed ID: 11672917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy, heat stability and safety of intranasally administered Bacillus subtilis spore or vegetative cell vaccines expressing tetanus toxin fragment C.
    Lee S; Belitsky BR; Brown DW; Brinker JP; Kerstein KO; Herrmann JE; Keusch GT; Sonenshein AL; Tzipori S
    Vaccine; 2010 Sep; 28(41):6658-65. PubMed ID: 20709005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-tetanus toxoid antibody production and protection against lethal doses of tetanus toxin in hu-PBL-SCID mice.
    Naito S; Okada Y; Takahashi M; Kato H; Taneichi M; Ami Y; Suzaki Y; Oka T; Okuma K; Morokuma K; Onodera H; Inoue M; Takahashi Y; Yamazaki S; Kimura H; Komuro K; Uchida T
    Int Arch Allergy Immunol; 2000 Oct; 123(2):149-54. PubMed ID: 11060487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An effective toxoid from tetanus toxin prepared by stepwise iodination of purified toxin.
    Soares HR; Nunes RL; Prado SM; Higashi HG; Heneine IF
    Biologicals; 1994 Mar; 22(1):29-33. PubMed ID: 8068311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunization of mice against tetanus with fragments of tetanus toxin synthesized in Escherichia coli.
    Fairweather NF; Lyness VA; Maskell DJ
    Infect Immun; 1987 Nov; 55(11):2541-5. PubMed ID: 3312002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and construction of immune phage antibody library against Tetanus neurotoxin: Production of single chain antibody fragments.
    Sadreddini S; Seifi-Najmi M; Ghasemi B; Kafil HS; Alinejad V; Sadreddini S; Younesi V; Jadidi-Niaragh F; Yousefi M
    Hum Antibodies; 2015 Dec; 23(3-4):73-9. PubMed ID: 27472865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Immunogenicity of the C Fragment of Tetanus Neurotoxin in Production of Tetanus Antitoxin.
    Yu R; Ji C; Xu J; Wang D; Fang T; Jing Y; Kwang-Fu Shen C; Chen W
    Biomed Res Int; 2018; 2018():6057348. PubMed ID: 30687751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral immunization against tetanus.
    Baljer G
    Dev Biol Stand; 1976; 33():63-71. PubMed ID: 955281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant activity of Mycobacterium bovis BCG expressing CRM197 on the immune response induced by BCG expressing tetanus toxin fragment C.
    Mazzantini RP; Miyaji EN; Dias WO; Sakauchi D; Nascimento AL; Raw I; Winter N; Gicquel B; Rappuoli R; Leite LC
    Vaccine; 2004 Jan; 22(5-6):740-6. PubMed ID: 14741167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid assessment of tetanus vaccine-induced immunity in Bangladesh and the Gambia.
    Ramakrishnan G; Wright M; Alam M; Naylor C; Kabir M; Zerin A; Ferdous T; Pedersen K; Hennig BJ; Donowitz JR; Wegmuller R; Haque R; Petri WA; Herbein J; Gilchrist CA
    Diagn Microbiol Infect Dis; 2017 Mar; 87(3):272-274. PubMed ID: 27916543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens.
    Galen JE; Gomez-Duarte OG; Losonsky GA; Halpern JL; Lauderbaugh CS; Kaintuck S; Reymann MK; Levine MM
    Vaccine; 1997; 15(6-7):700-8. PubMed ID: 9178472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.